Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.

Huntington's disease (HD) is a neurodegenerative disorder caused by a dominant CAG-repeat expansion in the huntingtin gene. Microglial activation is a key feature of HD pathology, and is present before clinical disease onset. The kynurenine pathway (KP) of tryptophan degradation is activated in...

Full description

Bibliographic Details
Main Authors: David W Donley, Marley Realing, Jason P Gigley, Jonathan H Fox
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0250606
_version_ 1829489464452317184
author David W Donley
Marley Realing
Jason P Gigley
Jonathan H Fox
author_facet David W Donley
Marley Realing
Jason P Gigley
Jonathan H Fox
author_sort David W Donley
collection DOAJ
description Huntington's disease (HD) is a neurodegenerative disorder caused by a dominant CAG-repeat expansion in the huntingtin gene. Microglial activation is a key feature of HD pathology, and is present before clinical disease onset. The kynurenine pathway (KP) of tryptophan degradation is activated in HD, and is thought to contribute to disease progression. Indoleamine-2,3-dioxygenase (IDO) catalyzes the first step in this pathway; this and other pathway enzymes reside with microglia. While HD brain microglia accumulate iron, the role of iron in promoting microglial activation and KP activity is unclear. Here we utilized the neonatal iron supplementation model to investigate the relationship between iron, microglial activation and neurodegeneration in adult HD mice. We show in the N171-82Q mouse model of HD microglial morphologic changes consistent with immune activation. Neonatal iron supplementation in these mice promoted neurodegeneration and resulted in additional microglial activation in adults as determined by increased soma volume and decreased process length. We further demonstrate that iron activates IDO, both in brain lysates and purified recombinant protein (EC50 = 1.24 nM). Brain IDO activity is increased by HD. Neonatal iron supplementation further promoted IDO activity in cerebral cortex, altered KP metabolite profiles, and promoted HD neurodegeneration as measured by brain weights and striatal volumes. Our results demonstrate that dietary iron is an important activator of microglia and the KP pathway in this HD model, and that this occurs in part through a direct effect on IDO. The findings are relevant to understanding how iron promotes neurodegeneration in HD.
first_indexed 2024-12-15T00:07:08Z
format Article
id doaj.art-09f6d8fb20fd4f8f8e9c185b729c4aa6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-15T00:07:08Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-09f6d8fb20fd4f8f8e9c185b729c4aa62022-12-21T22:42:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01165e025060610.1371/journal.pone.0250606Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.David W DonleyMarley RealingJason P GigleyJonathan H FoxHuntington's disease (HD) is a neurodegenerative disorder caused by a dominant CAG-repeat expansion in the huntingtin gene. Microglial activation is a key feature of HD pathology, and is present before clinical disease onset. The kynurenine pathway (KP) of tryptophan degradation is activated in HD, and is thought to contribute to disease progression. Indoleamine-2,3-dioxygenase (IDO) catalyzes the first step in this pathway; this and other pathway enzymes reside with microglia. While HD brain microglia accumulate iron, the role of iron in promoting microglial activation and KP activity is unclear. Here we utilized the neonatal iron supplementation model to investigate the relationship between iron, microglial activation and neurodegeneration in adult HD mice. We show in the N171-82Q mouse model of HD microglial morphologic changes consistent with immune activation. Neonatal iron supplementation in these mice promoted neurodegeneration and resulted in additional microglial activation in adults as determined by increased soma volume and decreased process length. We further demonstrate that iron activates IDO, both in brain lysates and purified recombinant protein (EC50 = 1.24 nM). Brain IDO activity is increased by HD. Neonatal iron supplementation further promoted IDO activity in cerebral cortex, altered KP metabolite profiles, and promoted HD neurodegeneration as measured by brain weights and striatal volumes. Our results demonstrate that dietary iron is an important activator of microglia and the KP pathway in this HD model, and that this occurs in part through a direct effect on IDO. The findings are relevant to understanding how iron promotes neurodegeneration in HD.https://doi.org/10.1371/journal.pone.0250606
spellingShingle David W Donley
Marley Realing
Jason P Gigley
Jonathan H Fox
Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
PLoS ONE
title Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
title_full Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
title_fullStr Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
title_full_unstemmed Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
title_short Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
title_sort iron activates microglia and directly stimulates indoleamine 2 3 dioxygenase activity in the n171 82q mouse model of huntington s disease
url https://doi.org/10.1371/journal.pone.0250606
work_keys_str_mv AT davidwdonley ironactivatesmicrogliaanddirectlystimulatesindoleamine23dioxygenaseactivityinthen17182qmousemodelofhuntingtonsdisease
AT marleyrealing ironactivatesmicrogliaanddirectlystimulatesindoleamine23dioxygenaseactivityinthen17182qmousemodelofhuntingtonsdisease
AT jasonpgigley ironactivatesmicrogliaanddirectlystimulatesindoleamine23dioxygenaseactivityinthen17182qmousemodelofhuntingtonsdisease
AT jonathanhfox ironactivatesmicrogliaanddirectlystimulatesindoleamine23dioxygenaseactivityinthen17182qmousemodelofhuntingtonsdisease